HEXIM1/P–TEFb complex controls RNA polymerase II pause release and immediate early gene induction following neuronal depolarization

Read full text
Authors: Myo Htet, Camila Estay-Olmos, Lan Hu, Yiyang Wu, Brian E. Powers, Clorissa D. Campbell, Aishwarya Rameshwar, Mohamed R. Ahmed, Timothy J. Hohman, Yanling Wang, Julie A. Schneider, David A. Bennett
+5 more Vilas Menon, Philip L. De Jager, Garrett A. Kaas, Roger J. Colbran, Celeste B. Greer
Cited by: 1
References: 96

Abstract

Cognitive processes require de novo gene transcription in neurons. Memory requires the rapid and robust transcription of a class of genes called immediate early genes (IEGs). IEG transcription is facilitated by the formation of a poised basal state, in which RNA polymerase II (RNAP2) initiates transcription, but remains paused downstream of the promoter. Upon neuronal depolarization, the paused RNAP2 is released to complete the synthesis of mRNA transcripts, a process stimulated by positive transcription elongation factor b (P-TEFb). In many cell types, P-TEFb is sequestered into a large inactive complex containing Hexamethylene bisacetamide inducible 1 (HEXIM1), but the impact of this interaction on neuronal gene transcription is not yet fully understood. In this study, we found that neuronal expression levels of HEXIM1 mRNA are highly correlated with impaired cognition in Alzheimer's disease. It is also induced in the hippocampus during memory formation, and following depolarization in neurons. The role of HEXIM1 in neuronal gene transcription was then explored in murine neuronal cultures where we found that calcium frees P-TEFb from the HEXIM1 inhibitory complex. Modulation of P-TEFb by inhibiting the activity of the CDK9 subunit of this complex significantly impacts IEG induction, particularly during repeated depolarization. Our findings indicate that HEXIM1 in complex with P-TEFb plays an important role in establishing and resetting the poised RNAP2 state, enabling efficient activation of genes necessary for synaptic plasticity.

Fields of Study & Subjects

RNA and protein synthesis mechanisms Immunodeficiency and Autoimmune Disorders Genetics and Neurodevelopmental Disorders

Publication details

Journal / source
Journal of Biological Chemistry
Publisher
Elsevier BV
Volume
302
Issue
4
Pages
111325–111325
Publication date
25 February 2026
Language
EN